Amneal Pharmaceuticals, Inc.
AMRX· Nasdaq
AMRXAmneal Pharmaceuticals, Inc.
Filed May 9, 2019 · 10-Q · 39 days after period end · 0001723128-19-000079
| Metric | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|
| Revenue | $446.12M | $275.19M | $225.68M |
| Net Income | -$47.88M | $0.00 | $42.26M |
| EPS Diluted | -$0.37 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Amneal Pharmaceuticals, Inc. · CIK 1723128 · Engraved from SEC EDGAR
ended Mar 31, 2019 · filed May 9, 2019 · 39 d after period end
